172 related articles for article (PubMed ID: 26847361)
1. Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris.
Kaushik N; Rohila D; Arora U; Raut R; Lamminmäki U; Khanna N; Batra G
BMC Biotechnol; 2016 Feb; 16():12. PubMed ID: 26847361
[TBL] [Abstract][Full Text] [Related]
2. [Characterization and secreted expression of dengue virus type I-IV envelope glycoprotein domain III in Pichia pastoris].
Cai JP; Qian F; Wang JY; Zhao Y; Xu XJ; Jin WR; Che XY
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Aug; 44(8):721-5. PubMed ID: 21055023
[TBL] [Abstract][Full Text] [Related]
3. Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies.
Poddar A; Ramasamy V; Shukla R; Rajpoot RK; Arora U; Jain SK; Swaminathan S; Khanna N
BMC Biotechnol; 2016 Jun; 16(1):50. PubMed ID: 27301568
[TBL] [Abstract][Full Text] [Related]
4. Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice.
Arora U; Tyagi P; Swaminathan S; Khanna N
Vaccine; 2013 Jan; 31(6):873-8. PubMed ID: 23261049
[TBL] [Abstract][Full Text] [Related]
5. Pichia pastoris-expressed dengue virus type 2 envelope domain III elicits virus-neutralizing antibodies.
Batra G; Raut R; Dahiya S; Kamran N; Swaminathan S; Khanna N
J Virol Methods; 2010 Jul; 167(1):10-6. PubMed ID: 20211204
[TBL] [Abstract][Full Text] [Related]
6. A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice.
Ramasamy V; Arora U; Shukla R; Poddar A; Shanmugam RK; White LJ; Mattocks MM; Raut R; Perween A; Tyagi P; de Silva AM; Bhaumik SK; Kaja MK; Villinger F; Ahmed R; Johnston RE; Swaminathan S; Khanna N
PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006191. PubMed ID: 29309412
[TBL] [Abstract][Full Text] [Related]
7. Dengue-1 envelope protein domain III produced in Pichia pastoris: potential use for serological diagnosis.
Cardoso SA; Paixão VF; Oliveira MD; Honda ER; Oliveira LL; da Silva CC; De Paula SO
Protein Expr Purif; 2013 Nov; 92(1):9-13. PubMed ID: 23993978
[TBL] [Abstract][Full Text] [Related]
8. Induction of virus-neutralizing antibodies and T cell responses by dengue virus type 1 virus-like particles prepared from Pichia pastoris.
Tang YX; Jiang LF; Zhou JM; Yin Y; Yang XM; Liu WQ; Fang DY
Chin Med J (Engl); 2012 Jun; 125(11):1986-92. PubMed ID: 22884066
[TBL] [Abstract][Full Text] [Related]
9. Dengue envelope-based 'four-in-one' virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice.
Rajpoot RK; Shukla R; Arora U; Swaminathan S; Khanna N
Sci Rep; 2018 Jun; 8(1):8643. PubMed ID: 29872153
[TBL] [Abstract][Full Text] [Related]
10. Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody.
Wahala WM; Kraus AA; Haymore LB; Accavitti-Loper MA; de Silva AM
Virology; 2009 Sep; 392(1):103-13. PubMed ID: 19631955
[TBL] [Abstract][Full Text] [Related]
11. Production of dengue virus envelope protein domain III-based antigens in tobacco chloroplasts using inducible and constitutive expression systems.
Gottschamel J; Lössl A; Ruf S; Wang Y; Skaugen M; Bock R; Clarke JL
Plant Mol Biol; 2016 Jul; 91(4-5):497-512. PubMed ID: 27116001
[TBL] [Abstract][Full Text] [Related]
12. An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes.
Etemad B; Batra G; Raut R; Dahiya S; Khanam S; Swaminathan S; Khanna N
Am J Trop Med Hyg; 2008 Sep; 79(3):353-63. PubMed ID: 18784226
[TBL] [Abstract][Full Text] [Related]
13. Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties.
Liu Y; Zhou J; Yu Z; Fang D; Fu C; Zhu X; He Z; Yan H; Jiang L
BMC Microbiol; 2014 Dec; 14():233. PubMed ID: 25520151
[TBL] [Abstract][Full Text] [Related]
14. Yeast-produced subunit protein vaccine elicits broadly neutralizing antibodies that protect mice against Zika virus lethal infection.
Zhang W; Qu P; Li D; Zhang C; Liu Q; Zou G; Dupont-Rouzeyrol M; Lavillette D; Jin X; Yin F; Huang Z
Antiviral Res; 2019 Oct; 170():104578. PubMed ID: 31394119
[TBL] [Abstract][Full Text] [Related]
15. Eliciting cross-neutralizing antibodies in mice challenged with a dengue virus envelope domain III expressed in Escherichia coli.
Yang J; Zhang J; Chen W; Hu Z; Zhu J; Fang X; Yuan W; Li M; Hu X; Tan Y; Hu F; Rao X
Can J Microbiol; 2012 Apr; 58(4):369-80. PubMed ID: 22420529
[TBL] [Abstract][Full Text] [Related]
16. Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies.
Mani S; Tripathi L; Raut R; Tyagi P; Arora U; Barman T; Sood R; Galav A; Wahala W; de Silva A; Swaminathan S; Khanna N
PLoS One; 2013; 8(5):e64595. PubMed ID: 23717637
[TBL] [Abstract][Full Text] [Related]
17. Optimization of conditions for secretion of dengue virus type 2 envelope domain III using Pichia pastoris.
Batra G; Gurramkonda C; Nemani SK; Jain SK; Swaminathan S; Khanna N
J Biosci Bioeng; 2010 Oct; 110(4):408-14. PubMed ID: 20538539
[TBL] [Abstract][Full Text] [Related]
18. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
Khanam S; Pilankatta R; Khanna N; Swaminathan S
Vaccine; 2009 Oct; 27(43):6011-21. PubMed ID: 19665609
[TBL] [Abstract][Full Text] [Related]
19.
Shukla R; Rajpoot RK; Arora U; Poddar A; Swaminathan S; Khanna N
Front Microbiol; 2017; 8():2644. PubMed ID: 29367852
[TBL] [Abstract][Full Text] [Related]
20. Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2.
Arora U; Tyagi P; Swaminathan S; Khanna N
J Nanobiotechnology; 2012 Jul; 10():30. PubMed ID: 22794664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
